Very high linezolid clearance in a critically ill patient: A case report suggesting a novel metabolic induction mechanism.

Stojanova, Jana; Brown, Jeremy D; Reuter, Stephanie E; Marriott, Deborah J E

Stojanova, Jana; Brown, Jeremy D; Reuter, Stephanie E; Marriott, Deborah J E.

Afiliación

Stojanova J; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, NSW, Australia; School of Clinical Medicine, St Vincent's Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW Sydney, NSW, Australia. Electronic address: jana.stojanova@svha.org.au.
Brown JD; Clinical Microbiology and Infectious Diseases Department, St. Vincent's Hospital, Sydney, NSW, Australia.
Reuter SE; UniSA Clinical & Health Sciences, University of South Australia, Adelaide, SA, Australia.
Marriott DJE; Clinical Microbiology and Infectious Diseases Department, St. Vincent's Hospital, Sydney, NSW, Australia; School of Clinical Medicine, St Vincent's Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW Sydney, NSW, Australia.

Int J Antimicrob Agents ; 63(6): 107170, 2024 Jun.

Article en En | MEDLINE | ID: mdl-38604388

Asunto(s)

Antibacterianos; Enfermedad Crítica; Linezolid; Humanos; Antibacterianos/farmacocinética; Antibacterianos/uso terapéutico; Linezolid/farmacocinética; Linezolid/uso terapéutico; Tasa de Depuración Metabólica

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Crítica / Linezolid / Antibacterianos Límite: Humans Idioma: En Revista: Int J Antimicrob Agents Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google